OpenBilldrug price receipt

NADAC week of 2026-10-14

FOSFOMYCIN 3 GM SACHET

For 1 unit (EA)

Pharmacies pay

$26.22 filed

1 × $26.22036 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$56.97 filed

1 × $56.96652 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.2× estimated

Medicare paid 2.2× what pharmacies pay.

Part D averages every strength and form sold under “Fosfomycin Tromethamine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$35.15 estimated

$26.22 + $3.93 (15%) + $5.00 fee per fill = $35.15

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FOSFOMYCIN 3 GM SACHET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “fosfomycin tromethamine” and “granules for oral solution”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “granule, for solution”, “granule” and “powder” and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Aurobindo Pharma Limited, Amneal Pharmaceuticals NY LLC and Ascend Laboratories, LLC.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 8 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $26.22 for 1 unit (EA) (1 × $26.22036 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 7 labelers

LabelerNDCsPharmacies pay per unit
XIROMED LLC2$26.22036 per EA filed
Amneal Pharmaceuticals NY LLC1$26.22036 per EA filed
Ascend Laboratories, LLC1$26.22036 per EA filed
Aurobindo Pharma Limited1$26.22036 per EA filed
Cipla USA Inc.1$26.22036 per EA filed
Kesin Pharma Corporation1$26.22036 per EA filed
Precision Dose, Inc.1$26.22036 per EA filed
Not listed as a package in the FDA directory3$26.22036 per EA filed

When these prices took effect

All 11 NDCs, with labeler and price
  • 59651-0651-03 · Aurobindo Pharma Limited · $26.22036 per EA · eff. 2026-09-23 filed
  • 60219-3955-01 · Amneal Pharmaceuticals NY LLC · $26.22036 per EA · eff. 2026-09-23 filed
  • 60219-3955-03 · not listed as a package in the FDA directory · $26.22036 per EA · eff. 2026-09-23 filed
  • 67877-0749-57 · Ascend Laboratories, LLC · $26.22036 per EA · eff. 2026-09-23 filed
  • 68094-0064-01 · not listed as a package in the FDA directory · $26.22036 per EA · eff. 2026-09-23 filed
  • 68094-0064-20 · Precision Dose, Inc. · $26.22036 per EA · eff. 2026-09-23 filed
  • 69097-0579-67 · Cipla USA Inc. · $26.22036 per EA · eff. 2026-09-23 filed
  • 70700-0268-94 · XIROMED LLC · $26.22036 per EA · eff. 2026-09-23 filed
  • 70700-0268-99 · XIROMED LLC · $26.22036 per EA · eff. 2026-09-23 filed
  • 81033-0024-03 · not listed as a package in the FDA directory · $26.22036 per EA · eff. 2026-09-30 filed
  • 81033-0024-11 · Kesin Pharma Corporation · $26.22036 per EA · eff. 2026-09-23 filed

What Medicare paid

Medicare Part D paid $56.97 for 1 unit (EA), at an average of $56.96652 per EA in 2024 (2024-01-01 to 2024-12-31) for “Fosfomycin Tromethamine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 129,002 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

9 of the product’s 11 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for FOSFOMYCIN 3 GM SACHET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Fosfomycin Tromethamine / Fosfomycin Tromethamine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists 8 of its 11 NDCs (it does not list the other 3) as dosage forms “GRANULE”, “GRANULE, FOR SOLUTION”, “POWDER” with route “ORAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.